Lysentech Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8.18M
- Investors
-
6
Lysentech General Information
Description
Operator of a drug development company intended to develop antibiotics that control antibiotic-resistant bacteria. The company's core technologies include the development of antibacterials using bacteriophages and phage-derived endolysins and the development of target-specific oncolytic bacteriophages, enabling physicians to receive anticancer drugs that target and kill cancer cells using bacteriophages.
Contact Information
Website
lysentech.comCorporate Office
- Room 215, Natural Science Building
- 81 Oedae-ro, Cheoin-gu
- Yongin, Gyeonggi-do
- South Korea
Corporate Office
- Room 215, Natural Science Building
- 81 Oedae-ro, Cheoin-gu
- Yongin, Gyeonggi-do
- South Korea
Lysentech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 22-Dec-2021 | $8.18M | Completed | Startup | ||
| 2. Accelerator/Incubator | 01-Sep-2019 | Completed | Startup | |||
| 1. Early Stage VC | 01-Jan-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lysentech Comparisons
Industry
Financing
Details
Lysentech Competitors (1)
One of Lysentech’s competitors is Locus Biosciences, a Venture Capital-Backed company based in Morrisville, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Locus Biosciences | Venture Capital-Backed | Morrisville, NC |
Lysentech Patents
Lysentech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024531962-A | Novel polypeptide and antibiotic against gram-negative bacteria containing the same | Pending | 19-Aug-2021 | ||
| CA-3229593-A1 | Novel polypeptides and antibiotics against gram-negative bacterium comprising the same | Pending | 19-Aug-2021 | ||
| EP-4137568-A1 | Novel polypeptides and antibiotics against gram-negative bacterium comprising the same | Inactive | 19-Aug-2021 | ||
| WO-2023022546-A1 | Novel polypeptides and antibiotics against gram-negative bacterium comprising the same | Inactive | 19-Aug-2021 | ||
| US-12102667-B2 | Polypeptides and antibiotics against gram-negative bacterium comprising the same | Active | 19-Aug-2021 | A61K38/47 |
Lysentech Signals
Lysentech Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| J Curve Investment | Venture Capital | Minority | ||
| Kingo Investment Partners | Venture Capital | Minority | ||
| Medytox | Corporation | Minority | ||
| Partners Investment | Venture Capital | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | Minority |
Lysentech FAQs
-
When was Lysentech founded?
Lysentech was founded in 2019.
-
Where is Lysentech headquartered?
Lysentech is headquartered in Yongin, South Korea.
-
What is the size of Lysentech?
Lysentech has 4 total employees.
-
What industry is Lysentech in?
Lysentech’s primary industry is Drug Discovery.
-
Is Lysentech a private or public company?
Lysentech is a Private company.
-
What is Lysentech’s current revenue?
The current revenue for Lysentech is .
-
How much funding has Lysentech raised over time?
Lysentech has raised $8.18M.
-
Who are Lysentech’s investors?
J Curve Investment, Kingo Investment Partners, Medytox, Partners Investment, and Tech Incubator Program for Startup are 5 of 6 investors who have invested in Lysentech.
-
Who are Lysentech’s competitors?
Locus Biosciences is a competitor of Lysentech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process